Series B startup

Who invested in AffaMed Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$170Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $170MMar 2021
Investors
2
See who backed them

The rounds

  1. Mar 2021
    Series B$170M

    Source recorded

Everyone who backed them

Ring CapitalVC firm1round
Partners InvestmentVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about AffaMed Therapeutics

Who invested in AffaMed Therapeutics?

AffaMed Therapeutics's investors include Ring Capital and Partners Investment.

How much has AffaMed Therapeutics raised?

AffaMed Therapeutics has raised $170M across 1 round since 2021.

When did AffaMed Therapeutics last raise?

AffaMed Therapeutics's most recent round was a Series B of $170M in Mar 2021.

What was AffaMed Therapeutics's biggest round?

Its most recent round, $170M in Mar 2021, is also its largest on record.

Who backed AffaMed Therapeutics first?

AffaMed Therapeutics's first round on record, in Mar 2021, was backed by Ring Capital and Partners Investment.

What stage is AffaMed Therapeutics at?

AffaMed Therapeutics's latest named round is a Series B, in Mar 2021.

Companies like AffaMed Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.